Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate
STRAHLENTHERAPIE UND ONKOLOGIE, vol.195, no.10, pp.872-881, 2019 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 195 Issue: 10
- Publication Date: 2019
- Doi Number: 10.1007/s00066-019-01429-6
- Journal Name: STRAHLENTHERAPIE UND ONKOLOGIE
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.872-881
- Hacettepe University Affiliated: Yes
Abstract
Purpose To evaluate the potential benefit of curative radiotherapy (RT) to the primary tumor in metastatic castration-resistant prostate cancer (mCRPC) patients treated with abiraterone.